On August 30, 2019, the California Senate Appropriations Committee failed to move AB-228 out of the committee and instead held the bill on “Suspense” during its final hearing of the 2019 legislative session. As we have written previously, AB-228
Continue Reading
CBD marketers can learn something from the food industry. And it has nothing to do with the regulatory morass around whether CBD can be legally added to foods. It’s about managing the risk of consumer false advertising litigation. Lawsuits filed
Continue Reading
Last February, FDA issued three warning letters to companies marketing cannabidiol (CBD) products as dietary supplements. FDA reviewed the companies’ websites and concluded that claims that CBD products could treat post-traumatic stress disorder, lupus, cancer, and other conditions rendered the
Continue Reading
